GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 111 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,335,000 | -13.3% | 159,903 | -15.7% | 0.29% | -24.9% |
| Q3 2020 | $2,694,000 | -0.1% | 189,728 | +3.4% | 0.39% | -12.7% |
| Q2 2020 | $2,698,000 | +193.6% | 183,446 | -17.7% | 0.44% | +137.6% |
| Q1 2020 | $919,000 | -36.5% | 222,958 | -25.9% | 0.19% | +4.5% |
| Q4 2019 | $1,447,000 | -16.7% | 300,783 | +4.9% | 0.18% | -29.1% |
| Q3 2019 | $1,737,000 | – | 286,618 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|